Catalyst Wire Dossier Catalyst Wire Dossier

Tirzepatide (Mounjaro)

tirzepatide · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Tirzepatide (Mounjaro), covering 2023-04-24 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Tirzepatide in MetALD [Phase 2]

See pricing